{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:12:39Z","timestamp":1768590759286,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["912-03-033l 2003"],"award-info":[{"award-number":["912-03-033l 2003"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["RUL99\/1992"],"award-info":[{"award-number":["RUL99\/1992"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019962","name":"Cancer Couch Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["NHS 98.113"],"award-info":[{"award-number":["NHS 98.113"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.rpth.2023.102193","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T21:33:42Z","timestamp":1693431222000},"page":"102193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Coagulation factors II, V, VII, IX, X and XI and mortality \u2013 a cohort study"],"prefix":"10.1016","volume":"7","author":[{"given":"Eng Soo","family":"Yap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem M.","family":"Lijfering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne C.","family":"Cannegieter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.102193_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1649589","article-title":"Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"70","author":"Conlan","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102193_bib2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/jth.13071","article-title":"Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study","volume":"13","author":"Yap","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102193_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","article-title":"Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study","volume":"2","author":"Meade","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.102193_bib4","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.ATV.19.7.1776","article-title":"The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study","volume":"19","author":"Tracy","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2023.102193_bib5","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/jth.13698","article-title":"Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study","volume":"15","author":"Olson","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102193_bib6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5551\/jat.3673","article-title":"Coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease","volume":"17","author":"Yamagishi","year":"2010","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.rpth.2023.102193_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2141.2006.06021.x","article-title":"Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture","volume":"133","author":"Lowe","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2023.102193_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2023.102193_bib9","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/blood.V95.12.3678.012k45_3678_3682","article-title":"High levels of factor IX increase the risk of venous thrombosis","volume":"95","author":"van Hylckama Vlieg","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.102193_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2141.1998.00664.x","article-title":"Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene","volume":"101","author":"Guasch","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2023.102193_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001155","article-title":"Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors","volume":"9","author":"Flinterman","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.rpth.2023.102193_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.rpth.2023.102193_bib13","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1160\/TH17-02-0079","article-title":"Coagulation factor and protease pathways in thrombosis and cardiovascular disease","volume":"117","author":"Ten Cate","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102193_bib14","first-page":"1849","article-title":"Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation","volume":"157","author":"Erlich","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rpth.2023.102193_bib15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.5858\/2002-126-1405-EHFLAP","article-title":"Elevated hemostatic factor levels as potential risk factors for thrombosis","volume":"126","author":"Chandler","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.rpth.2023.102193_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1309\/AJCPAGOR4Q2IIKUG","article-title":"Elevated factor IX activity is associated with an increased odds ratio for both arterial and venous thrombotic events","volume":"140","author":"Heikal","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rpth.2023.102193_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/QC259F09UNMKVP0R","article-title":"Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events","volume":"126","author":"Yang","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rpth.2023.102193_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2015.09.015","article-title":"Lack of association of plasma factor XI with incident stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study","volume":"243","author":"Folsom","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rpth.2023.102193_bib19","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/j.1538-7836.2006.02237.x","article-title":"Plasma hemostatic factors and endothelial markers in four racial\/ethnic groups: the MESA study","volume":"4","author":"Lutsey","year":"2006","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923002467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923002467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:29:29Z","timestamp":1762864169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923002467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2475037923002467"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.102193","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation factors II, V, VII, IX, X and XI and mortality \u2013 a cohort study","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.102193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102193"}}